BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,447,835 | +185.3% | 223,843 | +244.4% | 0.02% | +216.7% |
| Q2 2023 | $2,961,400 | -45.3% | 65,000 | -51.3% | 0.01% | -45.5% |
| Q1 2023 | $5,410,704 | +1807.2% | 133,400 | +2296.7% | 0.01% | – |
| Q4 2022 | $283,699 | -96.6% | 5,566 | -96.4% | 0.00% | -100.0% |
| Q3 2022 | $8,347,000 | +2492.2% | 155,000 | +3630.4% | 0.01% | – |
| Q1 2022 | $322,000 | -98.9% | 4,155 | -98.8% | 0.00% | -100.0% |
| Q4 2021 | $28,895,000 | -61.3% | 336,591 | -63.7% | 0.03% | -53.6% |
| Q3 2021 | $74,622,000 | +385.4% | 927,800 | +385.8% | 0.06% | +300.0% |
| Q2 2021 | $15,374,000 | +9.8% | 190,979 | +15.0% | 0.01% | +16.7% |
| Q1 2021 | $14,005,000 | -52.5% | 166,054 | -54.8% | 0.01% | -45.5% |
| Q4 2020 | $29,459,000 | -38.5% | 367,185 | -38.3% | 0.02% | -38.9% |
| Q3 2020 | $47,872,000 | +37.1% | 595,380 | +46.8% | 0.04% | -12.2% |
| Q2 2020 | $34,916,000 | +429.2% | 405,605 | +398.6% | 0.04% | +355.6% |
| Q1 2020 | $6,598,000 | -29.0% | 81,348 | -26.9% | 0.01% | -10.0% |
| Q4 2019 | $9,298,000 | +104.5% | 111,215 | +113.9% | 0.01% | +66.7% |
| Q3 2019 | $4,547,000 | +454600.0% | 51,990 | +324837.5% | 0.01% | – |
| Q2 2019 | $1,000 | -100.0% | 16 | -100.0% | 0.00% | -100.0% |
| Q1 2019 | $8,294,000 | +4559.6% | 102,005 | +3657.1% | 0.01% | – |
| Q4 2018 | $178,000 | -76.5% | 2,715 | -76.8% | 0.00% | -100.0% |
| Q4 2017 | $758,000 | +2707.4% | 11,720 | +2149.5% | 0.00% | – |
| Q1 2017 | $27,000 | -98.2% | 521 | -98.4% | 0.00% | -100.0% |
| Q2 2016 | $1,508,000 | -80.6% | 33,352 | -82.4% | 0.00% | -83.3% |
| Q1 2016 | $7,773,000 | +159.6% | 189,223 | +141.0% | 0.02% | +200.0% |
| Q4 2015 | $2,994,000 | +156.8% | 78,500 | +121.1% | 0.01% | +100.0% |
| Q3 2015 | $1,166,000 | -94.2% | 35,500 | -87.6% | 0.00% | -93.0% |
| Q2 2015 | $19,966,000 | -33.4% | 285,500 | -34.7% | 0.04% | -39.4% |
| Q1 2015 | $29,969,000 | +485.8% | 437,486 | +526.8% | 0.07% | +343.8% |
| Q4 2014 | $5,116,000 | +3865.9% | 69,796 | +3777.6% | 0.02% | – |
| Q3 2014 | $129,000 | -99.7% | 1,800 | -99.7% | 0.00% | -100.0% |
| Q2 2014 | $39,186,000 | +8.1% | 542,000 | +10.0% | 0.16% | -23.9% |
| Q1 2014 | $36,254,000 | +153.8% | 492,700 | +139.9% | 0.21% | +204.3% |
| Q4 2013 | $14,287,000 | +497.3% | 205,400 | +464.3% | 0.07% | +483.3% |
| Q3 2013 | $2,392,000 | -68.2% | 36,400 | -66.4% | 0.01% | -65.7% |
| Q2 2013 | $7,514,000 | – | 108,475 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |